0.518
                                            Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten
HC Wainwright Lowers Plus Therapeutics (NASDAQ:PSTV) Price Target to $2.00 - MarketBeat
Will Plus Therapeutics Inc. outperform the marketShare Buyback & Safe Swing Trade Setups - newser.com
Will Plus Therapeutics Inc. stock maintain dividend yieldTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Will Plus Therapeutics Inc. stock gain from strong economyPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
What MACD signals say about Plus Therapeutics Inc.Earnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Is Plus Therapeutics Inc. stock positioned for digital transformationJuly 2025 Snapshot & Fast Moving Market Watchlists - newser.com
How Recent Developments Are Rewriting the Plus Therapeutics Investment Story - Yahoo Finance
How to use Fibonacci retracement on Plus Therapeutics Inc.Share Buyback & Daily Volume Surge Trade Alerts - newser.com
Why global investors buy Plus Therapeutics Inc. (XMP0) stockPortfolio Return Report & Fast Gain Stock Trading Tips - newser.com
Is Plus Therapeutics Inc. forming a reversal patternJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
How interest rate cuts could boost Plus Therapeutics Inc. stock2025 Price Momentum & Consistent Growth Stock Picks - newser.com
Is Plus Therapeutics Inc. forming a bottoming baseEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Plus Therapeutics stock price target lowered to $2 at H.C. Wainwright - Investing.com UK
Smart tools for monitoring Plus Therapeutics Inc.’s price action2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Plus Therapeutics (PSTV) Analyst Rating Update: Price Target Low - GuruFocus
HC Wainwright & Co. Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
How dovish Fed policy supports Plus Therapeutics Inc. (XMP0) stock2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
Order flow analysis tools used on Plus Therapeutics Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
Can Plus Therapeutics Inc. rally from current levelsJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com
Applying Wyckoff theory to Plus Therapeutics Inc. stock2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Plus Therapeutics Inc. benefit from macro trendsGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
How Plus Therapeutics Inc. (XMP0) stock compares with tech leadersTrade Entry Report & Smart Money Movement Tracker - newser.com
What momentum shifts mean for Plus Therapeutics Inc.Market Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can a trend reversal in Plus Therapeutics Inc. lead to recoveryMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Candlestick signals on Plus Therapeutics Inc. stock todayQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Should you hold or exit Plus Therapeutics Inc. nowTrend Reversal & Daily Momentum Trading Reports - newser.com
Why Plus Therapeutics Inc. stock remains on watchlistsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Applying Elliott Wave Theory to Plus Therapeutics Inc.Market Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Is Plus Therapeutics Inc. stock positioned for long term growthMarket Risk Report & Real-Time Market Trend Scan - newser.com
Is Plus Therapeutics Inc. (XMP0) stock attractive for growth funds2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Can Plus Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Plus Therapeutics, Inc. (NASDAQ:PSTV) Given Average Rating of "Buy" by Brokerages - MarketBeat
D. Boral Capital Reiterates Buy Rating for Plus Therapeutics (NASDAQ:PSTV) - MarketBeat
Is Plus Therapeutics Inc. stock dividend yield sustainableQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
MSN Money - MSN
Plus Therapeutics’ ARISE Study: A New Hope for Fertility Treatment - MSN
Is Plus Therapeutics Inc. (XMP0) stock protected from inflationJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Plus Therapeutics (NASDAQ:PSTV) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):